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A B S T R A C T
A case of polyneuroradiculitis (Guillain-Barre Syndrome) is presented, which was diagnosed in a 62 year-old man af-
ter progressive weakness in the legs and arms and double vision, preceded by severe pain in the back. Diagnosis was
made on the basis of electromioneurography, a specific finding of cerebrospinal fluid (albumino-citological dissociation),
and the clinical course of the disease. Serological analysis of serum included Borellia Burgdorferi sensu lato (BBSL).
Positive findings (slowing of conduction velocity of sensor and motor neurones, and marked albumino-citological disso-
ciation), together with the dynamics of these findings on the 33rd, 67th and 101st days and one year and a half after the
first clinical signs of disease, indicated the possibility of BBSL infection. Because of the absence of clear clinical and
serological signs of other infections it was assumed that BBSL might be the possible trigger for Guillain-Barre Syn-
drome. The fact that there were no obvious clinical signs of infection with BBSL, only serological, suggests that in the
case of unclear aetiology of Guillain-Barre Syndrome BBSL should not be excluded.
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Introduction
Guillain-Barre Syndrome is an immunologically me-
diated disorder in which the immunological system at-
tacks the roots of the spinal and cranial nerves, resulting
in focal inflammation, damage to the myelin sheath, and
even of the axons themselves. The true cause of this au-
toimmune disorder is unknown and the reason why
Guillain-Barre Syndrome attacks only certain individu-
als is also not known.
Vaccination, pregnancy, malignant diseases, bone
marrow transplantation are also connected with the oc-
currence of this syndrome1,2. The main clinical charac-
teristic of the syndrome is progressive symmetrical mus-
cular weakness and paralysis of the extremities, which
develops within 3–4 weeks. It is accompanied by pare-
sthesia in the hands and feet, back pain and weak or ab-
sent muscular reflexes.
Specific antiborrelia IgM antibodies can be deter-
mined in the serum of patients 3–6 weeks after infection,
and IgG antibodies after 1–3 months3. Damaged cranial
nerves are also not a rare occurrence and most fre-
quently involve oculogyria with consequent double vision
(diplopia), prozones and aniso corea4,5.
The pathognomic signs of Guillain-Barre Syndrome,
apart from the clinical status, are pathological changes
(lesions) in the cerebrospinal liquor and electrodiagno-
stic abnormalities of the peripheral nerves.
The course of the disease is generally monophasic and
the rate of relapse is around 30%. The most satisfactory
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treatment effect is achieved with plasmapherese and/or
intravenous application of immunoglobulins with symp-
tomatic therapy and careful monitoring. The mortality
rate is around 5%. Satisfactory recovery with slight or
minimal neurological defects in the peripheral nerves oc-
curs in 70–80% of patients5.
Our case is interesting because of the absence of obvi-
ous clinical signs of unusual infection, which can be in-
terpreted as possible triggers for the syndrome. Also the
serological findings were inconclusive. Consequently, the
possibility of infection with Borellia Burgdorferi Sensu
Lato was investigated.
Case report
The patient was male, aged 62 years, a geodesic tech-
nician. He was a non-smoker and denied alcohol con-
sumption. As a child he had suffered from rubella and
varicella. He had never had any serious illness apart
from appendicitis, resulting in appendectomy, in 1989.
Digestive tract bleeding had occurred on one occasion
during the same year. Gastroscopy was found to be nor-
mal. In childhood he was vaccinated against various dis-
eases, after which he did not receive any vaccine. He de-
nied ever losing consciousness or having significantly
disturbed consciousness. He had not previously consul-
ted a physician for cervical or lumbosacral radiculopathy,
and stated that in principle he “avoided the use” of any
kind of medication. Over-sensitivity to medication had
not been noticed. Family case history normal. He denied
being bitten by a tick. Because of the nature of his work
and hobby (hunting) he spends much of his time in the
countryside. The area in which he spends most time is
known as an endemic focal area for meningoencephalitic
ticks and other diseases, such as Lymes disease, tulare-
mia and human erlichiosis. He denied having travelled to
risk areas for infectious diseases.
The disease started at the beginning of 2001 with un-
expected, severe pain in the abdomen beneath the right
rib arch. The patient spent a sleepless night.
During the following five days the pain spread
throughout the abdomen, back and to both legs. During
the day the pain was less intense, while at night it was
exceptionally severe and analgesics failed to alleviate the
pain. On the sixth day vision deteriorated in his right
eye, with double vision. He was unable to read and even-
tually his sight was completely lost in the right eye.
On the eighth day his legs felt weak and he was un-
able to walk. Severe pain continued in the abdomen and
legs and he was unable to sleep at night. During the day
he slept for very short periods, waking with severe pain.
Sphincter control was normal.
For the following ten days the situation was un-
changed. On the 24th day lumbar puncture was per-
formed and Guillain-Barre Syndrome was diagnosed on
the basis of the finding of cerebrospinal fluid, electro-
mioneurography, clinical status and disease course.
Because of the pain in his legs and insomnia, physical
therapy was carried out. From the 35th day of the dis-
ease, four treatments by plasmapheresis were performed
in intervals of three to four days.
The nape of the neck was free, Lasegue negative bilat-
erally. Double vision occurred in the ortho-position, right
bulbus lateral deviation. When looking to the left the
right bulbus was delayed, and when looking to the right
the left bulbus was delayed. Movements of the bulbus
higher and lower were restricted, dissociated. The identi-
cally round pupils showed normal reaction to light and
accommodation. Consensual reaction normal, moderate-
ly impaired vision in the right eye (at a distance of one
meter the patient was unable to count the fingers on the
hand of the examiner). Affective and spontaneous facio-
motorics symmetric, satisfactory, with no lateralisation
or loss of facial sensation. Other innervation of the cra-
nial nerves normal.
Basic physical strength of the arms symmetric, satis-
factory. The patient had difficulty raising his legs and
holding them in an antigravitational position, symmetri-
cally. Dorsal and plantar flexion of the feet severely im-
paired, symmetrically. The quality of all sensations was
decreased non-symmetrically towards the periphery on
the legs. The patient had normal sphincter control. Inde-
pendent reflexes in the legs absent and induced with dif-
ficulty in the arms, symmetrically. Abdominal reflexes
normal. Plantar responses induced with great difficulty
symmetrically. Remaining neurological status normal.
Intellectual and cognitive functions satisfactory. Psy-
chiatric functions satisfactory.
Routine laboratory findings (repeated several times)
were normal. All the serological findings for BBSL were
considered positive. Tumour markers: PSA total, CA
19–9, CEA normal; electrocardiogram (ECG) normal. Di-
gestive system: gastroscopy, ultrasound of the abdomen,
irrigography, computerised tomography (CT) of the ab-
domen – normal findings. X-ray of the whole spine – sus-
pected angioma of the L2 spine. X-ray of the pelvis nor-
mal.
Craniogram normal. CT of the brain normal. Nuclear
magnetic resonance (NMR) of the brain and whole spine,
electroencephalogram (EEG), Fundus oculi bilaterally –
normal findings.
Lumbosacral puncture: Pandy positive, proteins 2.0
gr/L, leukocytes 2/3, lymphocytes 5/3, glucose in liquor
(GUL) 3.5 mm/L, chlorides 124 mmol/L.
Electromioneurography (EMNG): (six weeks after the
start of the disease): severe loss of motoneurons in both
feet, slight loss of motoneurons in both lower legs and
both hands and a significant decrease of motor and sen-
sor neurone velocity. This finding, in correlation with the
clinical finding, indicated polyradicular neuropathy.
Results of the analysis of liquor and serum for B.
burgdorferi sensu lato (BBSL):
• Modified Kelly-Pettenkofer’s medium (MKP) was used
for cultivation of B. Burgdorferi sensu lato6. One ml of
CSF obtained by lumbal puncture was inoculated into
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a tube with 6.5 mL of MKP and cultivated at 33 °C for
nine weeks.
• IgM and IgG antibodies to BBSL in serum and CFS
were determined by indirect immunofluorescent test
(IFA) without absorption5. A local isolate of Borrelia
aafzeli was used as an antigen6.
• Titres of  1:256 in serum and  1:8 in CSF were inter-
preted as positive.
• There was no isolation of BBSL from CFS. Intratecal
borrelial IgG antibodies were negative.
All the above findings were considered positive sero-
logical findings for BBSL (Table 1).
Results of serological testing
After the third treatment by plasmapheresis vision
improved in the right eye and double vision was less pro-
nounced. The pain was less intense and the patient was
able to sleep. By the end of treatment the patient could
get up without help and walk a short distance with help,
slowly and with difficulty.
After physical rehabilitation in a spa for a period of
six weeks further improvement occurred. The patient
had no pain and was able to walk with a walking stick.
Four and a half months after commencement of the dis-
ease double vision completely disappeared.
One year after the commencement of disease and spe-
cific treatment the following were determined during a
routine neurological check-up. Subjectively: slight pare-
sthesia in both hands, the lower legs and feet, and in-
creased fatigue. Objectively: voluntary leg reflexes in-
duced with difficulty, basic motor function normal.
Moderately severe to severe loss of motoneurons in
the lower legs and feet, slight loss in the forearms and
hands.
Discussion
Guillain-Barre Syndrome was diagnosed in a male pa-
tient on the basis of the finding of cerebrospinal fluid,
electromioneurography, clinical status and course of the
disease. Because of the lack of obvious clinical and sero-
logical signs of other infections it was assumed that
BBSL might be the possible trigger for Guillain-Barre
Syndrome, and the fact that there were no clinical signs
of infection with BBSL, only serological, suggests that
when the aetiology is unclear the possibility of Guillain-
Barre Syndrome should not be ruled out.
Today Campilobacter infection is considered the most
frequent causal trigger of Guillain-Barre Syndrome in
25–40% of patients7–10. Importance is also attached to in-
fections with Epstein-Barr and cytomegalo viruses. If the
occurrence of Guillain-Barre Syndrome is preceded by a
viral infection it is possible for the virus to change the
nature of the cells of the nervous system so that its own
immunological system no longer recognises them and
consequently treats them like a foreign body (unknown
cell). Another possibility is the effect of the virus on the
immunological system, so that it hardly recognises the
cells attacking it11.
Correlation has been observed with other causal agents
of infectious diseases, including Mycoplasma of pneumo-
nia, leptospira, AIDS virus, BBSL5,12. In the second stage
of neuroborreliosis, which includes Garin-Biadoux-Bann-
wart’s Syndrome, lymphocytic meningitis, lymphocytic
meningoradiculitis, encephalitis, mielitis, BBSL infec-
tion can cause damage to the peripheral nervous system,
such as radiculoneuritis, which can result in the appear-
ance of Guillain-Barre Syndrome13,14. Neurological sym-
ptoms occur most frequently several weeks or months af-
ter the beginning of infection, when the
main clinical sign of the early stage of Erithema
migras (EM) disease has disappeared, if ever clinically
present. Evidence of neuroborelliosis is the isolation of
BBSL from liquor15. The finding is positive in 10% of pa-
tients.
Specific antiborrelia IgM antibodies can be deter-
mined in the serum of patients 3–6 weeks after infection,
and IgG antibodies after 1–3 months3. With the develop-
ment of the disease the percentage of seropositive find-
ings increases. The majority of patients with neuro-
borreliosis are reported at the end of summer, although
they are diagnosed during the whole year.
All known factors which could have triggered the dis-
ease in our patient were negative16–18. Thus, the question
arises of whether positive IgG antibodies to BBSL at the
commencement of the disease and their fourfold decrease
during one year is a sufficiently reliable indicator that it
was in fact infection with this causal agent which pre-
ceded and triggered the occurrence of Guillain-Barre
Syndrome in our patient. This hypothesis is further sup-
ported by epidemiological data, the occurrence of the dis-
ease in the winter months (incubation period), and ab-
sence of common symptoms of the disease, which usually
occur in the early manifest stage of infection with BBSL.
Whether or not it was necessary to include specific
antimicrobial therapy in the case of this patient, and
whether it can be assumed that at least one part of
Guillain-Barre Syndrome of unknown aetiology related
to the part that induced BBSL, are questions which re-
main unanswered.
A. Vrca et al.: Guillain-Barre Syndrome in Patients with Seroconversion of IgG Antibodies, Coll. Antropol. xx
xx
TABLE 1
RESULTS OF SEROLOGICAL TESTING
Serum




365 (one year) negative 1:256
547 (one and a half years) negative 1:258
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GUILLAIN-BARRE SINDROM U BOLESNIKA SA SEROKONVERZIJOM IgG ANTITIJELA
KASNO OSJETLJIVE BORRELIJE BURGDORFERI
S A @ E T A K
Prikazujemo slu~aj poliradikuloneuritisa (Guillain-Barre Sindroma) koji je dijagnosiciran u 62-godi{njeg mu{karca
nakon progresivne slabosti nogu i ruku i dvoslike, pra}ene jakom boli. Dijagnoza se temeljila na elektromiografiji,
specifi~ne promjene cerebrospinalnog likvora (albumino-citolo{ka disocijacija), i klini~ke karakteristike bolesti. Sero-
lo{ke analize seruma uklju~uju}i Borellia Burgdorferi kasno osjetljivi oblike (BBSL). Pozitivni testovi (usporenje provo-
|enja senzornim i motornim neuronima, i jasna albumino-citolo{ka disocijacija), zajedno sa dinamikom tih pokazatelja
33, 67, 101 dan i godinu i godinu i pol nakon prvih klini~kih znakova bolesti, upu}ivali su na mogu}u BBSL infekciju.
Odsustvo drugih jasnih klini~kih i serolo{kih znakova drugih infekcija mo`e upu}ivati na mogu}i BBSL uzrok Guilla-
rin-Barre Sindroma. Nije bilo klini~ki jasnih znakova infekcije sa BBSL, osim serologije, koji bi upu}ivali na mogu}u
nejasnu etiologiju Guillarin-Barre Sindroma sa BBSL koji bi je mogli isklju~iti.
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